Semnur Pharmaceuticals Secures $100M Equity Investment at $10/Share, 16x Current Price
SMNR has more than doubled off its 52-week low of $0.25.
Summary
Semnur Pharmaceuticals has secured a binding term sheet for a $100 million equity investment from iHolding Group. This investment, at $10.00 per share, represents a massive premium of over 16 times the company's current stock price of $0.60. This critical financing directly addresses the severe liquidity issues and going concern warning disclosed in the company's recent 10-Q and follows the termination of $120 million in prior financing. The deal is subject to due diligence and various approvals, so completion is not yet assured.
At the time of this announcement, SMNR was trading at $0.60 on OTC in the Life Sciences sector, with a market capitalization of approximately $138.1M. The 52-week trading range was $0.25 to $23.00. This news item was assessed with positive market sentiment and an importance score of 10 out of 10. Source: Wiseek News.